Treatment of depression in individuals living with HIV/AIDS

Michelle M. Primeau, Victoria Avellaneda, Dominique Musselman, Gilbert St. Jean, Lourdes Illa

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Depression is common in patients with HIV/AIDS, and can have an impact on quality of life, as well as various health outcomes. This study was designed to observe the efficacy of standard treatment of depression in human immunodeficiency virus (HIV) (+) individuals in an urban psychiatric clinic. Methods: This study consisted of a retrospective chart review of patients presenting for psychiatric services between January 1, 2008 and December 31, 2010. A total of 211 charts were examined for factors including diagnosis given at initial visit, health status, sociodemographic factors and comorbid illnesses, as well as treatment plan prescribed; of these, 132 patients were determined to be depressed at the initial evaluation (Beck Depression Inventory (BDI> 13) and to return for at least one follow-up visit. Results: Of the 132 depressed patients, 48 (36.4%) reached remission (BDI <13) at some point at follow-up, and an additional 12 (50.7%) achieved response (decrease in BDI of 50%). Remission correlated with having disability income and having a viral load that was not detectable. Conclusions: Depression is common in HIV/AIDS, and is important to treat. Furthermore, individuals with depression and HIV/AIDS respond at rates similar to what is seen in other depressed populations.

Original languageEnglish
Pages (from-to)336-344
Number of pages9
JournalPsychosomatics
Volume54
Issue number4
DOIs
StatePublished - Jul 1 2013

Fingerprint

Acquired Immunodeficiency Syndrome
HIV
Psychiatry
Therapeutics
Viral Load
Health Status
Quality of Life
Equipment and Supplies
AIDS/HIV
Health
Population
Charts
Remission

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Applied Psychology
  • Arts and Humanities (miscellaneous)

Cite this

Treatment of depression in individuals living with HIV/AIDS. / Primeau, Michelle M.; Avellaneda, Victoria; Musselman, Dominique; St. Jean, Gilbert; Illa, Lourdes.

In: Psychosomatics, Vol. 54, No. 4, 01.07.2013, p. 336-344.

Research output: Contribution to journalArticle

Primeau, MM, Avellaneda, V, Musselman, D, St. Jean, G & Illa, L 2013, 'Treatment of depression in individuals living with HIV/AIDS', Psychosomatics, vol. 54, no. 4, pp. 336-344. https://doi.org/10.1016/j.psym.2012.12.001
Primeau, Michelle M. ; Avellaneda, Victoria ; Musselman, Dominique ; St. Jean, Gilbert ; Illa, Lourdes. / Treatment of depression in individuals living with HIV/AIDS. In: Psychosomatics. 2013 ; Vol. 54, No. 4. pp. 336-344.
@article{14ccb8b346f6404d890ef122afb741d1,
title = "Treatment of depression in individuals living with HIV/AIDS",
abstract = "Background: Depression is common in patients with HIV/AIDS, and can have an impact on quality of life, as well as various health outcomes. This study was designed to observe the efficacy of standard treatment of depression in human immunodeficiency virus (HIV) (+) individuals in an urban psychiatric clinic. Methods: This study consisted of a retrospective chart review of patients presenting for psychiatric services between January 1, 2008 and December 31, 2010. A total of 211 charts were examined for factors including diagnosis given at initial visit, health status, sociodemographic factors and comorbid illnesses, as well as treatment plan prescribed; of these, 132 patients were determined to be depressed at the initial evaluation (Beck Depression Inventory (BDI> 13) and to return for at least one follow-up visit. Results: Of the 132 depressed patients, 48 (36.4{\%}) reached remission (BDI <13) at some point at follow-up, and an additional 12 (50.7{\%}) achieved response (decrease in BDI of 50{\%}). Remission correlated with having disability income and having a viral load that was not detectable. Conclusions: Depression is common in HIV/AIDS, and is important to treat. Furthermore, individuals with depression and HIV/AIDS respond at rates similar to what is seen in other depressed populations.",
author = "Primeau, {Michelle M.} and Victoria Avellaneda and Dominique Musselman and {St. Jean}, Gilbert and Lourdes Illa",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.psym.2012.12.001",
language = "English",
volume = "54",
pages = "336--344",
journal = "Psychosomatics",
issn = "0033-3182",
publisher = "American Psychiatric Publishing Inc.",
number = "4",

}

TY - JOUR

T1 - Treatment of depression in individuals living with HIV/AIDS

AU - Primeau, Michelle M.

AU - Avellaneda, Victoria

AU - Musselman, Dominique

AU - St. Jean, Gilbert

AU - Illa, Lourdes

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Background: Depression is common in patients with HIV/AIDS, and can have an impact on quality of life, as well as various health outcomes. This study was designed to observe the efficacy of standard treatment of depression in human immunodeficiency virus (HIV) (+) individuals in an urban psychiatric clinic. Methods: This study consisted of a retrospective chart review of patients presenting for psychiatric services between January 1, 2008 and December 31, 2010. A total of 211 charts were examined for factors including diagnosis given at initial visit, health status, sociodemographic factors and comorbid illnesses, as well as treatment plan prescribed; of these, 132 patients were determined to be depressed at the initial evaluation (Beck Depression Inventory (BDI> 13) and to return for at least one follow-up visit. Results: Of the 132 depressed patients, 48 (36.4%) reached remission (BDI <13) at some point at follow-up, and an additional 12 (50.7%) achieved response (decrease in BDI of 50%). Remission correlated with having disability income and having a viral load that was not detectable. Conclusions: Depression is common in HIV/AIDS, and is important to treat. Furthermore, individuals with depression and HIV/AIDS respond at rates similar to what is seen in other depressed populations.

AB - Background: Depression is common in patients with HIV/AIDS, and can have an impact on quality of life, as well as various health outcomes. This study was designed to observe the efficacy of standard treatment of depression in human immunodeficiency virus (HIV) (+) individuals in an urban psychiatric clinic. Methods: This study consisted of a retrospective chart review of patients presenting for psychiatric services between January 1, 2008 and December 31, 2010. A total of 211 charts were examined for factors including diagnosis given at initial visit, health status, sociodemographic factors and comorbid illnesses, as well as treatment plan prescribed; of these, 132 patients were determined to be depressed at the initial evaluation (Beck Depression Inventory (BDI> 13) and to return for at least one follow-up visit. Results: Of the 132 depressed patients, 48 (36.4%) reached remission (BDI <13) at some point at follow-up, and an additional 12 (50.7%) achieved response (decrease in BDI of 50%). Remission correlated with having disability income and having a viral load that was not detectable. Conclusions: Depression is common in HIV/AIDS, and is important to treat. Furthermore, individuals with depression and HIV/AIDS respond at rates similar to what is seen in other depressed populations.

UR - http://www.scopus.com/inward/record.url?scp=84880510187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880510187&partnerID=8YFLogxK

U2 - 10.1016/j.psym.2012.12.001

DO - 10.1016/j.psym.2012.12.001

M3 - Article

VL - 54

SP - 336

EP - 344

JO - Psychosomatics

JF - Psychosomatics

SN - 0033-3182

IS - 4

ER -